Hybrids of 1,2,3,4‐Tetrahydroisoquinoline‐Isatin as Potential CDK ‐5 Inhibitors: Synthesis, Biological Evaluations, and Molecular Docking Studies

Documents similaires

• Synthesis, Biological Activity, and Docking Studies of the Fused Pyrazoline and Thiazole Hybrids
  par: Nagma Banu Holalgod Abbas, et autres
  Publié: (2026)
• Potential Anticancer Agents Based on Monoterpenic Skeleton With Mono and Bis‐Isoxazoline Derivatives: Diastereoselective Synthesis, Experimental Study, Evaluation of Biological Activity, and Molecular Docking
  par: Abdoullah Bimoussa, et autres
  Publié: (2026)
• Design, Synthesis, and Biological Evaluation of 5‐Trifluoromethylpyrimidine Derivatives as EGFR Inhibitors Against T790M Mutation
  par: Kehui Chen, et autres
  Publié: (2026)
• Synthesis, Bioactivity Evaluation, Molecular Docking, ADMET , and Drug‐Likeness Studies of 4‐Chromanone Derivatives Containing a Thiosemicarbazone Moiety as Potential Antioxidants and α‐Glucosidase Inhibitors
  par: Tiantian Zhuang, et autres
  Publié: (2025)
• Highly Efficient One‐Pot Synthesis and Molecular Docking Studies of Pyrimido[4,5‐ b ]Quinoline and Pyrido[2,3‐ d ]Pyrimidine Derivatives as Potential α ‐Amylase Inhibitors
  par: Hemant Kumar Rundla, et autres
  Publié: (2026)